Acute pancreatitis and modified-release clarithromycin [2]

Annals of Pharmacotherapy

Volumn 38, Issue 3, 2004, Pages 508-509

  González Carro, Pedro ^a   Pérez Roldán, Francisco ^a   Legaz Huidobro, Maria Luisa ^a   De Acuña, Manuel Moraleda ^a   Nieto García, Juan Carlos ^a  

^a Mancha Centro General Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED DRUG RELEASE; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG WITHDRAWAL; EAR INFECTION; GASTROINTESTINAL SYMPTOM; HUMAN; IMAGE ANALYSIS; LETTER; MALE; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM;

ADULT; ANTI-BACTERIAL AGENTS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CLARITHROMYCIN; HUMANS; MALE; PANCREATITIS;

EID: 1242293851     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D115     Document Type: Letter

References (5)

1. Liviu L, Yair L. Yehuda S. Pancreatitis induced by clarithromycin. Ann Intern Med 1996;125:701-3.
2. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993;105:1886-99.
3. Wehrmann T, Pfeltzer C, Caspary WF. Effect of erythromycin on human biliary motility. Aliment Pharmacol Ther 1996;10:421-6.
4. Acalovschi M, Dumitrascu DL, Hagiu C. Oral clarithromycin enhances gallbladder emptying induced by a mixed mela in healthy subjects. Eur J Intern Med 2002;13:104-7.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.